Further evidence of genetic heterogeneity in Costello syndrome: involvement of the KRAS gene.

Article Details

Citation

Bertola DR, Pereira AC, Brasil AS, Albano LM, Kim CA, Krieger JE

Further evidence of genetic heterogeneity in Costello syndrome: involvement of the KRAS gene.

J Hum Genet. 2007;52(6):521-6. Epub 2007 Apr 28.

PubMed ID
17468812 [ View in PubMed
]
Abstract

Costello syndrome is an autosomal dominant disorder comprising growth deficiency, mental retardation, curly hair, coarse facial features, nasal papillomata, low-set ears with large lobes, cardiac anomalies, redundant skin in palms and soles with prominent creases, dark skin, and propensity to certain solid tumors. HRAS mutations have been implicated in approximately 85% of the affected cases. The clinical overlap among Costello, Noonan, and cardiofaciocutaneous syndromes is now better understood given their common molecular background, such that all these syndromes constitute a class of disorders caused by deregulated RAS-MAPK signaling. We report on a novel KRAS gene mutation in a patient presenting the clinical features typical of Costello syndrome and the additional findings seen in Noonan syndrome. This description emphasizes that a subset of patients with Costello syndrome could harbor mutations in other genes involved in the RAS-MAPK signaling.

DrugBank Data that Cites this Article

Polypeptides
NameUniProt ID
GTPase KRasP01116Details